Revealing transforming growth factor-β signaling transduction in human kidney by gene expression data mining

OMICS A Journal of Integrative Biology

Volumn 9, Issue 3, 2005, Pages 266-280

  Hu, Guanghui ^a   Jain, Komal ^a   Hurle, Mark ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC KIDNEY DISEASE; COMPUTER MODEL; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE EXPRESSION REGULATION; GENETIC SELECTION; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; KIDNEY FUNCTION; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 26844571056     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2005.9.266     Document Type: Article

References (37)

1. ABREU, J.G., KETPURA, N.I., REVERSADE, B., et al. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol. 4, 599-604.
2. ALEXANDER, D., JUDEX, M., MEYRINGER, R., et al. (2002). Transcription factor Egr-1 activates collagen ex-pression in immortalized fibroblasts or fibrosarcoma cells. Biol Chem 383, 1845-1853.
3. ANDOH, A., SHIMADA, M., TAKAYA, H., et al. (2000). Transforming growth factor-betal acts as a potent inhibitor of complement C3 biosynthesis in human pancreatic cancer cell lines. Pancreas 20, 138-145.
4. BOTTINGER, E.P., and BITZER, M. (2002). TGF-beta signaling in renal disease. J Am Soc Nephrol 13, 2600-2610.
5. CHENG, J., and GRANDE, J.P. (2002). Transforming growth factor-beta signal transduction and progressive renal dis-ease. Exp Biol Med (Maywood) 227, 943-956.
6. CHUNG, HJ., KIM, M., PARK, C.H., et al. (2004). ArrayXPath: mapping and visualizing microarray gene-expression data with integrated biological pathway resources using Scalable Vector Graphics. Nucleic Acids Res 32, W460-W464.
7. CREAN, J.K., LAPPIN, D., GODSON, C., et al. (2001). Connective tissue growth factor: an attractive therapeutic tar-get in fibrotic renal disease. Expert Opin Ther Targets 5, 519-530.
8. DAHLQUIST, K.D., SALOMONIS, N., VRANIZAN, K., et al. (2002). GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31, 19-20.
9. DERYNCK, R., and ZHANG, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family sig-nalling. Nature 425, 577-584.
10. FAN, F., JIN, S., AMUNDSON, S.A., et al. (2002). ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 21, 7488-7496.
11. GAEDEKE, J., NOBLE, N.A., and BORDER, W.A. (2004). Curcumin blocks multiple sites of the TGF-beta signal-ing cascade in renal cells. Kidney Int 66, 112-120.
12. GRUBER, F., HUFNAGL, P., HOFER-WARBINEK, R., et al. (2003). Direct binding of Nur77/NAK-l to the plas-minogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha-induced PAI-I expression. Blood 101, 3042-3048.
13. JIANG, Z., SEO, J.Y., HA, H., et al. (2003). Reactive oxygen species mediate TGF-beta !-induced plasminogen acti-vator inhibitor-1 upregulation in mesangial cells. Biochem Biophys Res Commun 309, 961-966.
14. KANG, Y., CHEN, C.R., and MASSAGUE, J. (2003). A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. MoI Cell 11, 915-926.
15. KAPLAN, F., LEDOUX, P., KASSAMALI, F.Q., et al. (1999). A novel developmentally regulated gene in lung mes-enchyme: homology to a tumor-derived trypsin inhibitor. Am J Physiol 276, L1027-L1036.
16. KRESSE, H., and SCHONHERR, E. (2001). Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189, 266-274.
17. LAMB, J., RAMASWAMY, S., FORD, H.L., et al. (2003). A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334.
18. LIANG, G., WOLFGANG, C.D., CHEN, B.P., et al. (1996). ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem 271, 1695-1701.
19. MAJOR, M.B., and JONES, D.A. (2004). Identification of a gadd45beta 3′ enhancer that mediates S. J Biol Chem 279, 5278-5287.
20. MASHIMA, T., UDAGAWA, S., and TSURUO, T. (2001). Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol 188, 352-358.
21. MOOTHA, V.K., LINDGREN, C.M., ERIKSSON, K.F., et al. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267-273.
22. OGAWA, K., CHEN, F., KIM, Y.J., et al. (2003). Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells. J Biol Chem 278, 30373-30381.
23. OWEN, A.B., STUART, J., MACH, K., et al. (2003). A gene recommender algorithm to identify coexpressed genes in C. elegans. Genome Res 13, 1828-1837.
24. PEAKE, P.W., O'GRADY, S., PUSSELL, B.A., et al. (1999). C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int 56, 1729-1736.
25. POSTIGO, A.A. (2003). Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 22, 2443-2452.
26. RAJAGOPALAN, D., and AGARWAL, P. (2004). Inferring pathways from gene lists using a literature-derived network of biological relationships. Bioinformatics 21, 788-793.
27. SAHARA, T., GODA, T., and OHGIYA, S. (2002). Comprehensive expression analysis of time-dependent genetic responses in yeast cells to low temperature. J Biol Chem 277, 50015-50021.
28. SCHNAPER, H.W., HAYASHIDA, T., HUBCHAK, S.C., et al. (2003). TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284, F243-F252.
29. SCHNEIDER, A., THAISS, F., RAU, H.P., et al. (1996). Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta. Kidney Int 50, 190-199.
30. TEN DIJKE, P., and HILL, C.S. (2004). New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29, 265-273.
31. VERRECCHIA, F., TACHEAU, C., SCHORPP-KISTNER, M., et al. (2001). Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation. Oncogene 20, 2205-2211.
32. WANG, J., CAO, Y., and STEINER, D.F. (2003). Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter. J Biol Chem 278, 32899-32904.
33. WANG, Q, ZHU, Y., and GRYGIELKO, E. (2002). Gene expression analysis of TGF-β effects on A498 human renal carcinoma cells. Microarray Data Analysis conference, September, 2002. Washington, DC.
34. WESTON, B.S., WAHAB, N.A., and MASON, R.M. (2003). CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha3beta1 integrin in human mesangial cells. J Am Soc Nephrol 14, 601-610.
35. YAN, C., WANG, H., and BOYD, D.D. (2002). ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem 277, 10804-10812.
36. YEUNG, K. Y., MEDVEDOVIC, M., and BUMGARNER, R.E. (2004). From co-expression to co-regulation: how many microarray experiments do we need? Genome Biol 5, R48.
37. YU, L., BORDER, W.A., HUANG, Y., et al. (2003). TGF-beta isoforms in renal fibrogenesis. Kidney Int 64, 844-856.